8 results
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
and reviewing and monitoring compliance with our code of conduct and ethics; and
reviewing and evaluating, at least annually, the performance … integrity, ethics, and values;
experience in corporate management, such as serving as an officer or former officer of a publicly-held company;
experience
S-3
EX-1.2
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
laws, rules, regulations and policies enforced by the FDA or any comparable Governmental Authority, or by any institutional review board, ethics review
8-K
EX-10.1
MLYS
Mineralys Therapeutics Inc
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
by any institutional review board, ethics review board or committee responsible for the oversight of such preclinical tests and studies and clinical trials
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
clinical investigators;
obtaining approval from one or more institutional review boards (IRBs) or ethics committees (ECs) at clinical trial sites … board (IRB), or ethics committee at each clinical site before each trial may be initiated;
performance of adequate and well-controlled human
DRS/A
613qb8mta uf
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
0ia2jftk4tdvh
4 Nov 22
Draft registration statement
12:00am
DRS
EX-4.2
8lw43 s784meclarvxb
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next